Summary: We have evaluated a new diagnostic kit for the determination of total estrogens in serum or plasma of pregnant women by means of an enzyme-immuno-assay.
Introduction
Free estrogen in a hydrolyzed, diluted serum sample is allowed to compete with an estriol-enzyme conjugate It is generally agreed that determination of estrogens is f -a ^.^ amQunt rf anti . estrogen serum . After incubaof clinical value in monitoring fetoplacental function.
üon ^ antibQdy i$ pre cipitated with a second antiMost laboratories measure total estrogen excretion in ^^ coupled tQ ceUulo$e (DASP® ) and the enzymatic 24-hour urine samples, activity is measured in the precipitated, bound fraction. With the introduction of protein binding methods (1, The coupled enzyme used in the test is horse-radish 2, 3) accurate measurement of the low estrogen conperoxidase (EC 1.11.1.7). Estrogen concentrations are centrations in serum or plasma has become possible. At read from a calibration curve, obtained with ä manupresent, several radip-immuno-assay kits for the measure-facturer-supplied estriol standard. In this study, we have ment of estrogens in pregnancy serum or plasma, instead evaluated this test with regard to precision, recovery, of urine, are commercially available. Recently, a new antibody affinity to different estrogens and practical and commercial kit (Estronostjcon®) based on the work of clinical usefulness as compared with our routine total Bosch et al. (4) , has become available.
estrogen determination in urine.
Materials and Methods

Equipment
All absorbance measurements were performed at 492 nm on a Beckman model 25 spectrophotometer. For pipetting serum samples, Helix pomatia extract and DASP® suspension we used Eppendorf pipets with Eppendorf disposable tips. For the addition of antiserum and conjugate we used a Hamilton PB 600 repeating dispenser, equipped with a 2.5 ml syringe. All other solutions were pipetted either with Seripettors® (Labora Mannĥ eim GmbH, W. Germany) or normal volumetric pipets.
Estrogens and estrogen conjugates
All estrogens and estrogen conjugates used in the study were purchased from Sigma Chemical Company. Names, catalogue numbers and abbreviations that will be used in figure 2 and Routine urine total estrogen determination The routine method which was used for urine total estrogen determinations was an Auto-Analyzer method, identical to the method described by Van Kessel et al. (5) . This method is based on ihelttrich technique (6).
Enzyme-immuno-assay for serum total estrogen determination
The enzyme-immuno-assay (Estronosticon®, Organon Technica B. V., Oss, The Netherlands) was performed according to the manufacturers' instructions. To reduce the reagent cost and the necessary sample volume (500 μΐ of serum accord to the instruction manual) we reduced all volumes mentioned in the instruction manual by half. All samples were analyzed in duplicate.
Manual estrogen determinations
Stock solutions of estrogen conjugates, used in the hydrolysis experiments were analyzed for their real estrogen content by the method ofKreutzer & Meulendijk (7), based on the Kober reaction.
Creatinine determination
Creatinine was determined by the method of the Dutch Standâ rdizatiqn Committee on Clinical Chemistry.
Results
Precision
Six different sera from pregnant women were used for precision studies. Six different urine samples from pregnant women were used to compare the precisions of both methods. For day-to-day precision studies, the sera were analyzed 10 or 11 times in a period of about 2 weeks, and urines were analyzed 16 or 17 times within a period of about 2 months, during the studies, the samples were kept at ^ 20 °C until needed. The results are given in table 2.
Linearity
Linearity is mainly dependent on the amount of conjugated estrogens that can be hydrolyzed by the Helix pomatia extract in one hour; after this step in the analysis procedure, the hydrolyzed sample is diluted until the estrogen concentration falls within the range of the calibration curve (0.66-2.78 nmol/1). The hydrolyzing capacities of the Helix pomatia extract will be discussed later.
A representative example of a standard curve is shown in figure 1 .
Recovery
To 1 ml of 12 different serum samples from pregnant women 50 μΐ of different stock estriol solutions were added. All serum samples supplied with extra estriol were allowed to equilibrate overnight and were analyzed Tab. 2. Results of precision studies with human sera and urines. Serum samples were analyzed with the enzyme-immuno-assay, urine samples with the autoanalyzer method. Urine sample no. together with the original samples. All samples were analyzed in duplicate. Table 3 shows the results of these , recovery studies. Mean analytic recovery was found to be 102%.
Antiserum affinity for different estrogens
To check the antiserum affinity for the three most important estrogens, estrone, estradiol and estriol, we prepared standard solutions for each of the estrogens, with concentrations similar to those for a normal standard curve. Standard curves, obtained with the three different estrogens are visualized in figure 2.
Hydrolysis with Helix pomatia extract
The Helix pomatia extract contains sulphatase and glucuronidase. We checked the hydrolyzing capacities of the extract by adding small volumes of six different stock solutions, each containing a different estrogen 0.30 extra conjugates were then analyzed together with the original pool-serum for their estrogen concentration according to the normal procedure. In this experiment we used only estrone and estriol conjugates, since estradiol in serum is predominantly in the unconjugated form. The recoveries that were found for the different conjugates are shown in 
Preliminary clinical studies
The preliminary clinical studies included 14 pregnant women. Gestational lengths at the beginning of the studies ranged from 23 to 28 weeks. One pregnancy was complicated by severe hypertension, another one by severe maternal diabetes. The other 12 pregnancies proceeded without serious complications. At 9.00 a. m. during each 24 hour urine collection a blood sample was taken for total estrogen analysis. This procedure was continued for at least 5 weeks during each pregnancy.
L Urine
e calculated Spearman rank correlation coefficients to demonstrate the presence or absence of a significant trend in total estrogen value with increasing gestational length. In each case the gestational length was taken as one variable and either the total 24 hour urine estrogen excretion, or urinary estrogen/creatinine ratio or serum total estrogen concentration as the other. Table 5 summarized the results of these calculations for the 14 pregnancies. Weeks of gestation The left half of figure 3 illustrates the estrogen values from a 34-year-old gravida 3 para 2 with severe insulin dependent diabetes (patient no. 2). Estrogen values in serum and urine were low, but echoscopic examination indicated a normal growing fetus. At 35 weeks of gestation, a live, premature infant, birthweight 2180 g, was delivered by cesarian section. The right half of figure 3 shows the estrogen values from a 30^-y ear-old gravida 2 para 0 with severe hypertension (patient no. 4). Again, estrogen values in serum and urine were low. In this case only the serum estrogen concentrations showed a significantly falling trend. On echoscQpic examination fetal growth was found to be impaired and at 35 weeks of gestation a dead fetus, weighing 800 g was delivered.
On microscopic examination approximately 20% of the placenta appeared to be infarcted. Figure 4 shows the course of estrogen values in patients no. 14 and 8, who were hospitalized for threatened immature labor and moderate pregnancy induced hypertension, respectively. Both pregnancies continued without further complications and both patients were delivered of healthy infants. Finally, figure 5 illustrates two normal pregnancies (patients no. 7 and 9), resulting in full term, normal-birthweight infants.
Discussion
We have evaluated a new commercially available enzymeimmuno-assay for determination of total estrogens in serum or plasma.
The precision studies performed in urine with our routine Auto-Analyzer method and in serum with the new assay, show that both methods have comparable within-run precisions, whereas the serum assay has a better day-to-day precision. The coefficients of variation we found for the serum assay are comparable with values reported in the literature for radio-immuno-assay procedures (8, 9) . The recovery of added estriol was good; mean analytical recovery for all experiments was found to be 102%. One sample (no. 5 in table 3) showed a low recovery of 59%. We have no explanation for this.
The manufacturer of the enzyme-immiino-assay kit claims that the antiserum has equal affinity for estrone, estradiol and estriol. This is confirmed by our experiments with the standard solutions of each estrogen. The standard curves obtained with each estrogen were virtually equal.
Hydrolysis experiments were performed with estrogen conjugates that are found predominantly in serum. The results indicate that hydrolysis is virtually complete for all conjugates tested, except for estriol-3-sulphate, which shows a somewhat lower recovery. We have no explanation for this observation. A saline solution of the same conjugate was hydrolyzed completely.
The amounts of conjugates added to the serum pool were sufficient to produce final concentrations above the upper normal limit for full term pregnancies, as given by the manufacturer (about 3500 nmol/1). Therefore, it can be concluded that the Helix pomatia extract hydrolyzes virtually all conjugated estrogens present in a serum sample.
It is of practical interest that the enzyme-immuno-assay procedure is quite laborious. In particular, centrifugation and washing procedures are time consuming when large series are analyzed. On the other hand, many manual procedures for urine total estrogen determinations are also laborious, because of extraction and washing procedures. With proper equipment we were able to analyze 30-40 samples in duplicate within one working day. Similar values have been reported for radio-immunoassay procedures (8) . With an Auto-Analyzer, 100-125 samples can be analyzed within one day, but because of reagent preparation and starting up and calibration procedures the instrument has a lagtime of about 2 1 / 2 hours, which makes it less suitable for small series. Moreover, the instrument is quite expensive (about 100,000 Dutch Guilders).
The total estrogen concentrations obtained with the enzyme-immuno-assay are not directly comparable with values obtained with commercially available radioimmuno-assay kits, since these measure mostly only one type of estrogen. In the work of Bosch et al. (4) the authors have compared the enzyme-immuno-assay with a radio-immuno^assay, using the same antibody. Both methods showed a good correlation;
Our first clinical results suggest that total estrogens in serum and in urine provide similar information with respect to fetoplacental function. We have not always found a significant rise in serum estrogens with increasing gestational length in normal pregnancies, but this applies to urine determinations as well. According to table 5 serum total estrogens and urine total estrogens showed a similar result (R s significant (S) or not significant (NS) at the p < 0.05 level) in 10 out of 14 pregnancies. For serum total estrogens and urine estrogen/creatinine ratio the results were similar in 9 out of 14 pregnancies, while both urine values showed similar results in 9 out of 14 pregnancies.
Though the occurrence of diurnal variations of blood estrogens has been claimed (10), others (11, 12) have not been able to demonstrate ä significant diurnal rhythm. In our studies, diurnal variation is unlikely to have influenced the results, since all samples were taken at the same time of the day, i. e. 9.00 a. m.
A disadvantage of using urine samples is the difficulty of obtaining a reliable 24-hour collection. Though the estrogen/creatinine ratio can be used to circumvent this problem (13) , it has been shown that clearances of estrogen and creatinine can vary independently in cases of complicated pregnancy (14) . Because of this, and because of the results of this study, we feel that the enzyme-immuno-assay of total estrogens in serum can be considered an attractive alternative to the determination of total estrogens in urine for monitoring of the fetoplacental unit.
In contrast to methods for serum estrogen determinations that use radioactive tracers, no permit or special counting equipment is needed for the enzyme-immunoâ ssay of serum total estrogens, which makes the method more widely applicable.
